Protective effect of bisphosphonate on the cortical bone at key locations of the femur in aromatase inhibitor-associated bone loss: A three-dimensional cortical bone mapping study

Aromatase inhibitor treatment in breast cancer is associated with accelerated bone loss and an increased risk of fracture. Bisphosphonates (BPs) are the mainstay treatment of aromatase inhibitor-associated bone loss (AIBL), which might improve femoral bone at key locations prone to fracture. To test...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Namki, Burm, Seung Won, Treece, Graham, Ye Kim, Jee, Hwan Kim, Min, Lee, Seunghyun, Shin, Sungjae, Rhee, Yumie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728402/
https://www.ncbi.nlm.nih.gov/pubmed/35024328
http://dx.doi.org/10.1016/j.jbo.2021.100409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728402/
https://www.ncbi.nlm.nih.gov/pubmed/35024328
http://dx.doi.org/10.1016/j.jbo.2021.100409

Ejemplares similares